BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37429070)

  • 1. Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.
    Lu F; Gao Y; Li E
    Stem Cell Res; 2023 Sep; 71():103162. PubMed ID: 37429070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.
    Qin Z; Sun L; Sun X; Su H; Gao X
    Stem Cell Res; 2021 Oct; 56():102562. PubMed ID: 34634758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a human TLR4 compound heterozygous knockout hESC line (WAe009-A-N) to model toll-like receptor 4 deficiency by CRISPR/Cas9 system.
    Ruan Y; Tian X; Li X; Zhang Y
    Stem Cell Res; 2023 Dec; 73():103225. PubMed ID: 37931537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a TRPM8 knockout hESC line (WAe009-A-A) derived from H9 using CRISPR/Cas9.
    Bai J; Zhang J; Fu W; Li S; Tian X; Li X; Zhao X; Dong J
    Stem Cell Res; 2023 Mar; 67():103040. PubMed ID: 36796252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9.
    Sun W; Li X; Dong J; Zhou Y
    Stem Cell Res; 2024 Feb; 74():103284. PubMed ID: 38118206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 mediated establishment of a human CSRP3 compound heterozygous knockout hESC line to model cardiomyopathy and heart failure.
    Sun L; Li J; Li E; Niu S; Qin Z; Zhi Q; Zhao J; Xiong H; Li Y; Jian L; Zhang L
    Stem Cell Res; 2020 Dec; 49():102077. PubMed ID: 33176267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.
    Wu F; Li X; Bai R; Li Y; Gao J; Lan F
    Stem Cell Res; 2020 Oct; 48():101930. PubMed ID: 32777767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system.
    Zhang P; Wang H; Li S; Guo T; Zhang R; Zhou P; Ding S
    Stem Cell Res; 2022 Oct; 64():102924. PubMed ID: 36182708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from human embryonic stem cells using CRISPR/Cas9.
    Seo HH; Han HW; Kim JH
    Stem Cell Res; 2020 May; 45():101735. PubMed ID: 32268246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.
    Wang W; Bai R; Song X
    Stem Cell Res; 2021 Aug; 55():102471. PubMed ID: 34332328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.
    Tian L; Wu F; Bai R; Ma S; Zheng H; Liu WJ; Wang Y
    Stem Cell Res; 2021 Aug; 55():102481. PubMed ID: 34419749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a FMR1 homozygous knockout human embryonic stem cell line (WAe009-A-16) by CRISPR/Cas9 editing.
    Giri S; Purushottam M; Viswanath B; Muddashetty RS
    Stem Cell Res; 2019 Aug; 39():101494. PubMed ID: 31280136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system.
    Wu X; Wang X
    Stem Cell Res; 2023 Jun; 69():103082. PubMed ID: 36963213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system.
    Dong T; Zhang S; Chang Y; Bai R; Jiang Y; Ma S; Li Y; Jiang HF; Lu WJ
    Stem Cell Res; 2021 Mar; 51():102196. PubMed ID: 33524674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a MSX1 knockout human embryonic stem cell line using CRISPR/Cas9 technology.
    Chiu W; Li A; Wang T; Li W; Zhang X
    Stem Cell Res; 2022 Apr; 60():102729. PubMed ID: 35247841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a TBX5 homozygous knockout embryonic stem cell line (WAe009-A-45) by CRISPR/Cas9 genome editing.
    Zhao T; Bai R; Wu F; Lu WJ; Zhang J
    Stem Cell Res; 2021 Mar; 51():102156. PubMed ID: 33497883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
    Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
    Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a TIMP3 knockout stem cell line via CRISPR/Cas9 system.
    Yi T; Liu J; Zhang S; He Y; Han J
    Stem Cell Res; 2023 Mar; 67():103034. PubMed ID: 36716678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9.
    Cao Y; Tang L; Su J; Wang H; Liang P; Rong K; Gong T
    Stem Cell Res; 2023 Oct; 72():103202. PubMed ID: 37708613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a TPM1 homozygous knockout embryonic stem cell line by CRISPR/Cas9 editing.
    Ma S; Xu Q; Bai R; Dong T; Peng Z; Liu X
    Stem Cell Res; 2021 Aug; 55():102470. PubMed ID: 34352617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.